Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. CPAP is considered the first-line treatment modality for OHS phenotype with concomitant severe obstructive sleep apnoea, whereas NIV is preferred in the minority of OHS patients with hypoventilation during sleep with no or milder forms of obstructive sleep apnoea (approximately <30% of OHS patients).

  2. If the sleep evaluation demonstrates OHS and severe obstructive sleep apnea (OSA) (apnea–hypopnea index ≥ 30), the panel recommends continuous positive airway pressure (CPAP) titration and treatment.

  3. 7 Ιουλ 2020 · This guideline covers investigation and management of obstructive sleep apnoea/hypopnoea syndrome, obesity hypoventilation syndrome and COPD-OSAHS overlap syndrome in adults and young people (16 and older).

  4. 20 Αυγ 2021 · This guideline covers obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS), and chronic obstructive pulmonary disease (COPD) with OSAHS overlap syndrome, providing advice on investigating and managing these related conditions.

  5. 18 Ιουλ 2015 · Obstructive Sleep Apnea has been receiving more and more attention while the diagnostic rate of Obesity Hypoventilation Syndrome is not high. Few studies directly evaluated the...

  6. 1 Αυγ 2019 · We suggest that: 1) clinicians use a serum bicarbonate level <27 mmol/L to exclude the diagnosis of OHS in obese patients with sleep-disordered breathing when suspicion for OHS is not very high...

  7. Clinical features to assess such risk include severe obesity with typical signs and symptoms of obstructive sleep apnea (OSA)/OHS and mild hypoxemia while awake, significant hypoxemia during sleep, or both.